MicroRNA-22 Slides (IMAGE)

University of California - Davis Health

MicroRNA-22 Slides

Caption

Ying Hu holds a slide with tissue samples. Gene therapy with microRNA-22 produced better survival outcomes than the current FDA-approved drug for liver cancer and without noticeable toxicity in new mouse study.

Credit

UC Davis Health.

Usage Restrictions

For reprint purposes only.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.